Chiropractors in Ignacio, CO Accepting Medicare
4 Chiropractors found. Showing 1 - 4
 Dr. Eric Jon Tessereau, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 430 Goddard Ave., Ignacio, CO 81137 Phone: 970-563-0330 Fax: 970-563-0331 |
 Garcia Chiropractic Wellness Center, Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 630 Goddard Avenue, Ignacio, CO 81137 Phone: 970-563-1006 Fax: 970-563-9591 |
Ignacio Chiropractic Chiropractor Medicare: Medicare Enrolled Practice Location: 630 Goddard Ave # 300, Ignacio, CO 81137 Phone: 970-563-1006 |
 Dr. Rebecca Marie York, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 630 Goddard Ave, Ignacio, CO 81137 Phone: 970-563-1006 |
News Archive
Early initiation of antiretroviral therapy can considerably reduce total HIV DNA levels
A team of researchers, led by Drs. Merlin Robb and Jintanat Ananworanich of the U.S. Military HIV Research Program at the Walter Reed Army Institute of Research, has found that when antiretroviral therapy (ART) is initiated during early acute HIV infection, it can significantly reduce total HIV DNA levels in the body, which may have implications for the goal of achieving long-term HIV remission.
Food labeling, product placement intervention can promote healthy choices
The use of color-coded "traffic light" food labels and changes in the way popular items are displayed appear to have produced a long-term increase in the choice of more healthful food items among customers in a large hospital cafeteria. A Massachusetts General Hospital team reports in the American Journal of Preventive Medicine that the previously reported changes in the proportions of more and less healthy foods purchased in the months after their program began have persisted up to two years after the labeling intervention was introduced.
Forward step in treatment of Allergic Rhinitis
Rigel Pharmaceuticals, Inc. has announced the presentation of clinical data for R112, the company's lead candidate for the treatment of allergic rhinitis, during a poster session at the annual meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI) in San Francisco, CA. The phase I/II single dose trial demonstrated that R112 was well tolerated and showed favorable biological effects.
Delayed prostate cancer intervention in low risk patients may not decrease ultimate chance for cure
A contemporary discussion exists whether patients with low-risk prostate cancer (CaP) are being overtreated with local treatment modalities. This is due to a combination of the older population affected and the slow doubling time of CaP.
› Verified 2 days ago